跳至主要内容
临床试验/JPRN-jRCT1032190165
JPRN-jRCT1032190165进行中(未招募)2 期

A clinical trial for efficacy and safety of carbon-ion radiotherapy on pelvic recurrent rectal cancer - J-CROS 1506 Rectum

Yamada Shigeru0 个研究点目标入组 32 人开始时间: 2019年12月18日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Confirmed pelvic recurrence of rectal cancer without distant metastasis. 2) Had radiographically measurable tumor. 3) Age to obtain consent is over 20 years. 4) Performance status (ECOG) of 0-2. 5) CMP and CBC with adequate hematologic variables as defined by WBC>=1000/mm3, Plt>=25,000/mm3, T-bil<3.0g/dL, AST<200 IU/L, ALT<200 IU/L, Cre<1.5 mg/dL,within 28 days of registration. 6) Expected to survive over 3 months. 7) Written consent form of the patient.

排除标准

  • 1) Tumor exceeds 15 cm in greatest dimension. 2) Subjects receiving other investigational agents they received chemotherapy within 2 weeks of CIRT. 3) they had an infection at the tumor site. 4) The tumor is infiltrating the digestive tract or bladder. 5) Prior radiation to the pelvis 6. resectable by radiographic. 7) with distant metastasis. 8) Active other cancer or within 2 years of disease free period after cancer treatment. 9) Serious complications. 10) Difficult to participate in clinical trials because of mental illness. 11) Patients who doctors judged that clinical trial participation is inappropriate.

研究者

发起方
Yamada Shigeru

相似试验